Tom Frohlich - 10 Nov 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Chief Operating Officer
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Nov 2021
Net transactions value
-$96,440
Form type
4
Filing time
12 Nov 2021, 19:00:26 UTC
Previous filing
09 Nov 2021
Next filing
02 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Sale $96,440 -6,230 -4.4% $15.48 134,619 10 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.